Operationalizing blood biomarkers across the care continuum

Blood-based biomarkers are emerging as frontline tools for assessing Alzheimer's disease pathology but using them responsibly in real-world practice requires clinical judgment. In this three-part panel discussion, Prof. Christopher Chen (National University of Singapore), Prof. Atsushi Iwata (Tokyo Metropolitan Geriatric Hospital), and Prof. So Yeon Jeon (Seoul National University Boramae Medical Center) discuss how clinicians, geriatricians, neurologists, and psychiatrists across Asia-Pacific can apply blood biomarkers from patient selection through interpretation to treatment monitoring.